Loading clinical trials...
Loading clinical trials...
A Prospective and Retrospective Interventional Study on the Bone-health Effectiveness of Applying Recombinant Factor VIII Fc (rFVIIIFc) to Patients With Hemophilia A (Prototype A)
Conditions
Interventions
serum biomarker.
Locations
1
Taiwan
Tri-Service General Hospital Hemophilia Care Center
Taipei, Neihu Dist., Taiwan
Start Date
July 14, 2023
Primary Completion Date
December 31, 2027
Completion Date
December 31, 2027
Last Updated
April 10, 2024
Lead Sponsor
Tri-Service General Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions